• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2020 Aug 19;S1198-743X(20)30500-0.
doi: 10.1016/j.cmi.2020.08.017. Online ahead of print.
Epidemiological and clinical characteristics of SARS-CoV-2 infections at a testing site in Berlin, Germany, March and April 2020 - A cross-sectional study


Friederike Maechler[SUP] 1 [/SUP], Maximilian Gertler[SUP] 2 [/SUP], Julia Hermes[SUP] 3 [/SUP], Welmoed van Loon[SUP] 2 [/SUP], Frank Schwab[SUP] 3 [/SUP], Brar Piening[SUP] 3 [/SUP], Shay Rojansky[SUP] 4 [/SUP], Franziska Hommes[SUP] 2 [/SUP], Franka Kausch[SUP] 2 [/SUP], Andreas K Lindner[SUP] 2 [/SUP], Susen Burock[SUP] 5 [/SUP], Heike R?ssig[SUP] 6 [/SUP], Claudia Hartmann[SUP] 6 [/SUP], Valerie Kirchberger[SUP] 6 [/SUP], Alexander Thieme[SUP] 7 [/SUP], Michael Behnke[SUP] 3 [/SUP], Petra Gastmeier[SUP] 3 [/SUP], Frank P Mockenhaupt[SUP] 2 [/SUP], Joachim Seybold[SUP] 6 [/SUP]



Affiliations

Abstract

Objective: In Berlin, the first public SARS-CoV-2 testing site started one day after the first case in the city occured. We describe epidemiological and clinical characteristics and aim at identifying risk factors for SARS-CoV-2 detection during the first six weeks of operation.
Methods: Testing followed national recommendations, but was also based on the physician?s discretion. We related patient characteristics to SARS-CoV-2 test positivity for exploratory analyses using a cross-sectional, observational study design.
Results: Between March 3 and April 13, 2020, 5179 patients attended the site (median age 34 years; IQR 26-47 years). The median time since disease onset was 4 days (IQR 2-7 days). Among 4333 patients tested, 333 (7.7%) were positive. Test positivity increased up to 10.3% (96/929) during the first three weeks and then declined, paralleling Germany's lock-down and the course of the epidemic in Berlin. Strict adherence to testing guidelines resulted in 10.4% (262/2530) test positivity, compared to 3.9% (71/1803) among patients tested for other indications. A nightclub was a transmission hotspot; 27.7% (26/94) of one night's visitors were found positive. Smell and/or taste dysfunction indicated COVID-19 with 85.6% specificity (95%CI 82.1-88.1%). Some 4% (14/333) of those infected were asymptomatic. Risk factors for detection of SARS-CoV-2 infection were recent contact to a positive case (second week after contact, OR 3.42; 95%CI 2.48-4.71), travel to regions of high pandemic activity (e.g. Austria, OR 4.16; 95%CI 2.48-6.99), recent onset of symptoms (second week, OR 3.61; 95%CI 1.87-6.98), and an impaired sense of smell/taste (4.08; 95%CI 2.36-7.03).
Conclusions: In this young population, early-onset presentation of COVID-19 resembled flu-like symptoms, except for smell and/or taste dysfunction. Risk factors for SARS-CoV-2 detection were return from regions with high incidence and contact to confirmed SARS-CoV-2 cases, particularly when tests were administered within the first two weeks after contact and/or onset of symptoms.

Keywords: COVID-19; SARS-CoV-2; asymptomatic; coronavirus; olfaction disorders; screening.
 
Back
Top Bottom